CHMP Issues Positive Opinion for Ruxolitinib Cream for Adults With Moderate AD The Dermatology Digest Source link
LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE) BioSpace Source link
Ivarmacitinib Proves Effective in Treating Moderate to Severe Atopic Dermatitis Docwire News Source link
(delgocitinib) Cream in Chinese Patients with Moderate to Severe Chronic Hand Eczema (CHE) Business Wire Source link